These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7037354)

  • 21. Treatment of respiratory tract infections with a combination of amoxycillin and clavulanic acid.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):647-9. PubMed ID: 4093205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The protective effect of clavulanic acid in a combined formulation on the concentration of amoxycillin in the urine of patients with urinary tract infections.
    Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):12A-13A. PubMed ID: 7046103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
    Fomina IP
    Antibiot Khimioter; 1997; 42(12):29-32. PubMed ID: 9480651
    [No Abstract]   [Full Text] [Related]  

  • 24. Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
    Cuffini AM; De Renzi G; Tullio V; Paizis G; Carlone NA
    Drugs Exp Clin Res; 1996; 22(1):9-15. PubMed ID: 8839632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection.
    Fast MV; Nsanze H; D'Costa LJ; Plummer FA; Karasira P; Maclean IW; Ronald AR
    Lancet; 1982 Sep; 2(8297):509-11. PubMed ID: 6125676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment with amoxicillin and clavulanic acid of urinary tract infections in patients with spinal injuries].
    Du Plessis DJ; Celliers D; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):8A-11A. PubMed ID: 6979806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentin: laboratory studies.
    Farrell ID; Turner PJ
    Scott Med J; 1982; 27 Spec No.():S21-3. PubMed ID: 6762661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amoxycillin and clavulanic acid in the treatment of urinary tract infections in children.
    Ruberto U; D'Eufemia P; Martino F; Giardini O
    J Int Med Res; 1989; 17(2):168-71. PubMed ID: 2721814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria.
    Leigh DA; Bradnock K; Marriner JM
    J Antimicrob Chemother; 1981 Mar; 7(3):229-36. PubMed ID: 6974165
    [No Abstract]   [Full Text] [Related]  

  • 30. Amoxycillin injectable: a review of its antibacterial spectrum, pharmacokinetics and therapeutic use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Sep; 18(3):169-84. PubMed ID: 387371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The beta-lactamase stability of amoxycillin with the beta-lactamase inhibitor, clavulanic acid.
    Reading C; Farmer T; Cole M
    J Antimicrob Chemother; 1983 Jan; 11(1):27-32. PubMed ID: 6600741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid.
    Wise R; Bennett SA; Dent J
    J Antimicrob Chemother; 1984 Jun; 13(6):603-10. PubMed ID: 6469882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-lactamase inhibition with clavulanic acid supplementing standard amoxycillin-based triple therapy does not increase Helicobacter pylori eradication rate.
    Crispino P; Iacopini F; Pica R; Consolazio A; Bella A; Cassieri C; Nardi F; Paoluzi P
    Dig Liver Dis; 2005 Nov; 37(11):826-31. PubMed ID: 16169304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Practical implications of bacterial resistance to antibiotics. Attempts to fight it].
    Denys A
    Otolaryngol Pol; 1997; 51 Suppl 25():171-4. PubMed ID: 9757685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
    García-Rodríguez JA; García Sánchez JE; Trujillano I; Muñoz-Bellido JL
    J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Friedel HA; Campoli-Richards DM; Goa KL
    Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic antibacterial activity of clavulanic acid and amoxicillin against beta-lactamase-producing strains of Haemophilus ducreyi.
    Girouard YC; Maclean IW; Ronald AR; Albritton WL
    Antimicrob Agents Chemother; 1981 Jul; 20(1):144-5. PubMed ID: 6974538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Todd PA; Benfield P
    Drugs; 1990 Feb; 39(2):264-307. PubMed ID: 2184003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
    Campoli-Richards DM; Brogden RN
    Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid.
    Ninane G; Joly J; Kraytman M; Piot P
    Lancet; 1978 Jul; 2(8083):257. PubMed ID: 79045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.